常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-5.22/-0.25
|
|
企业价值
58.12M
|
| 资产负债 |
|
每股账面净值
1.70
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
614.96M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/09/06 02:33 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines. |

0.84 
